Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
CN |
|
Anheuser-Busch Inbev SA
MIL:1ABI
|
BE |
|
Water Ways Technologies Inc
XTSX:WWT
|
CA |
|
D
|
Dongsung Chemical Co Ltd
KRX:102260
|
KR |
|
Zett Corp
TSE:8135
|
JP |
|
Fukuda Denshi Co Ltd
TSE:6960
|
JP |
|
S
|
Samsung Electronics Co Ltd
SWB:SSUN
|
KR |
|
Media Kobo Inc
TSE:3815
|
JP |
|
H
|
Hobonichi Co Ltd
TSE:3560
|
JP |
|
Invesque Inc
TSX:IVQ.U
|
CA |
|
China Merchants Commercial Real Estate Investment Trust
HKEX:1503
|
HK |
|
S
|
Sta Lucia Land Inc
XPHS:SLI
|
PH |
|
Aym Syntex Ltd
NSE:AYMSYNTEX
|
IN |
|
Yanbu National Petrochemicals Company SJSC
SAU:2290
|
SA |
|
Shenzhen Huijie Group Co Ltd
SZSE:002763
|
CN |
|
Southern Province Cement Company SJSC
SAU:3050
|
SA |
|
Keisei Electric Railway Co Ltd
TSE:9009
|
JP |
|
IndoStar Capital Finance Ltd
NSE:INDOSTAR
|
IN |
|
H
|
H-One Co Ltd
TSE:5989
|
JP |
|
Aramark
NYSE:ARMK
|
US |
|
Core Lithium Ltd
ASX:CXO
|
AU |
Bankruptcy Probability
Shenzhen Kangtai Biological Products Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shenzhen Kangtai Biological Products Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
15.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shenzhen Kangtai Biological Products Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shenzhen Kangtai Biological Products Co Ltd has total debt of 1.9B CNY. This includes both short-term (14.4m CNY) and long-term (1.8B CNY) debt.
You can find a full breakdown on its Balance Sheet.
